IBDEI1NP ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27715,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,27716,0)
 ;;=C50.919^^132^1320^121
 ;;^UTILITY(U,$J,358.3,27716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27716,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,27716,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,27716,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,27717,0)
 ;;=C62.90^^132^1320^159
 ;;^UTILITY(U,$J,358.3,27717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27717,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,27717,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,27717,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,27718,0)
 ;;=D03.9^^132^1320^161
 ;;^UTILITY(U,$J,358.3,27718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27718,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,27718,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,27718,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,27719,0)
 ;;=C45.0^^132^1320^162
 ;;^UTILITY(U,$J,358.3,27719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27719,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,27719,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,27719,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,27720,0)
 ;;=C90.01^^132^1320^164
 ;;^UTILITY(U,$J,358.3,27720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27720,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,27720,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,27720,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,27721,0)
 ;;=C90.00^^132^1320^165
 ;;^UTILITY(U,$J,358.3,27721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27721,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,27721,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,27721,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,27722,0)
 ;;=C94.6^^132^1320^166
 ;;^UTILITY(U,$J,358.3,27722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27722,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,27722,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,27722,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,27723,0)
 ;;=D61.82^^132^1320^167
 ;;^UTILITY(U,$J,358.3,27723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27723,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,27723,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,27723,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,27724,0)
 ;;=D47.9^^132^1320^168
 ;;^UTILITY(U,$J,358.3,27724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27724,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,27724,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,27724,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,27725,0)
 ;;=D53.9^^132^1320^172
 ;;^UTILITY(U,$J,358.3,27725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27725,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,27725,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,27725,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,27726,0)
 ;;=D47.4^^132^1320^173
 ;;^UTILITY(U,$J,358.3,27726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27726,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,27726,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,27726,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,27727,0)
 ;;=D59.1^^132^1320^27
 ;;^UTILITY(U,$J,358.3,27727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27727,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,27727,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,27727,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,27728,0)
 ;;=D51.3^^132^1320^187
 ;;^UTILITY(U,$J,358.3,27728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27728,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,27728,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,27728,2)
 ;;=^5002287
